doi.org/10.1126/scitranslmed.aau5907

The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells

Katrin Mestermann

,

Theodoros Giavridis

,

..., Michael Hudecek

Science Translational Medicine14.60

Volume: 11, Issue: 499

Published: Jul 3, 2019

Paper Fields

Paper Details

Title

The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells

DOI

doi.org/10.1126/scitranslmed.aau5907

Published Date

Jul 3, 2019

Journal

Science Translational Medicine

Volume

11

Issue

499

Notes

History